Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain +2 more
wiley +1 more source
Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: a case report and review of the literature. [PDF]
Chang L +4 more
europepmc +1 more source
Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus following pembrolizumab therapy. [PDF]
Marchionni E +4 more
europepmc +1 more source
Orchestration of Skin Pathology in Cutaneous Lupus Erythematosus by HLA Class I Down-Regulated Senescent Epidermal Basal Cells. [PDF]
Yamamoto S +13 more
europepmc +1 more source
Spotlight: What's New in JEADV – Editor‐in‐Chief's Selection
JEADV Clinical Practice, Volume 5, Issue 2, Page 367-372, June 2026.
Carle Paul
wiley +1 more source
Positive Direct Immunofluorescence in Rowell Syndrome: Further Support for a Subtype of Cutaneous Lupus Erythematosus. [PDF]
Bissenas A +3 more
europepmc +1 more source
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY [PDF]
Victoria P. Werth +4 more
openalex +1 more source
Erythema and scale in cutaneous lupus erythematosus significantly impacts patient quality of life and disease course impression. [PDF]
Lu G +6 more
europepmc +1 more source
903 Cardiovascular risk management in cutaneous and cutaneous with systemic lupus erythematosus [PDF]
Megan Zhao +3 more
openalex +1 more source
Tinea Incognito Caused by <i>Microsporum</i> spp. Mimicking Subacute Cutaneous Lupus Erythematosus-Case Report. [PDF]
Kasprowicz-Furmańczyk M +1 more
europepmc +1 more source

